|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:PTPRG-FHIT (FusionGDB2 ID:HG5793TG2272) |
Fusion Gene Summary for PTPRG-FHIT |
Fusion gene summary |
Fusion gene information | Fusion gene name: PTPRG-FHIT | Fusion gene ID: hg5793tg2272 | Hgene | Tgene | Gene symbol | PTPRG | FHIT | Gene ID | 5793 | 2272 |
Gene name | protein tyrosine phosphatase receptor type G | fragile histidine triad diadenosine triphosphatase | |
Synonyms | HPTPG|PTPG|R-PTP-GAMMA|RPTPG | AP3Aase|FRA3B | |
Cytomap | ('PTPRG')('FHIT') 3p14.2 | 3p14.2 | |
Type of gene | protein-coding | protein-coding | |
Description | receptor-type tyrosine-protein phosphatase gammaH_RG317H01.1protein tyrosine phosphatase gammaprotein tyrosine phosphatase, receptor type, gamma polypeptidereceptor type protein tyrosine phosphatase gammareceptor tyrosine phosphatase gammareceptor-t | bis(5'-adenosyl)-triphosphataseAP3A hydrolasediadenosine 5',5'''-P1,P3-triphosphate hydrolasedinucleosidetriphosphatase | |
Modification date | 20200327 | 20200313 | |
UniProtAcc | . | P49789 | |
Ensembl transtripts involved in fusion gene | ENST00000495879, ENST00000295874, ENST00000474889, | ENST00000295874, ENST00000474889, ENST00000495879, | |
Fusion gene scores | * DoF score | 18 X 14 X 10=2520 | 27 X 20 X 11=5940 |
# samples | 22 | 32 | |
** MAII score | log2(22/2520*10)=-3.51784830486262 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(32/5940*10)=-4.21431912080077 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: PTPRG [Title/Abstract] AND FHIT [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PTPRG(61734656)-FHIT(60522712), # samples:5 | ||
Anticipated loss of major functional domain due to fusion event. | PTPRG-FHIT seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PTPRG-FHIT seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PTPRG-FHIT seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. PTPRG-FHIT seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | FHIT | GO:0006163 | purine nucleotide metabolic process | 9323207 |
Fusion gene breakpoints across PTPRG (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across FHIT (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-E9-A228-01A | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
ChimerDB4 | LIHC | TCGA-RC-A6M4-01A | PTPRG | chr3 | 61734656 | - | FHIT | chr3 | 60807705 | - |
ChimerDB4 | LIHC | TCGA-RC-A6M4-01A | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
ChimerDB4 | PRAD | TCGA-XQ-A8TA-01A | PTPRG | chr3 | 61734656 | - | FHIT | chr3 | 60522712 | - |
ChimerDB4 | PRAD | TCGA-XQ-A8TA | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
ChimerDB4 | SKCM | TCGA-D3-A3C6-06A | PTPRG | chr3 | 61734656 | - | FHIT | chr3 | 60522712 | - |
Top |
Fusion Gene ORF analysis for PTPRG-FHIT |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-5UTR | ENST00000495879 | ENST00000468189 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
3UTR-5UTR | ENST00000495879 | ENST00000468189 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
3UTR-5UTR | ENST00000495879 | ENST00000476844 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
3UTR-5UTR | ENST00000495879 | ENST00000476844 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
3UTR-5UTR | ENST00000495879 | ENST00000492590 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
3UTR-5UTR | ENST00000495879 | ENST00000492590 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
3UTR-intron | ENST00000495879 | ENST00000341848 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
3UTR-intron | ENST00000495879 | ENST00000341848 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
3UTR-intron | ENST00000495879 | ENST00000466788 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
3UTR-intron | ENST00000495879 | ENST00000466788 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
5CDS-5UTR | ENST00000295874 | ENST00000341848 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
5CDS-5UTR | ENST00000295874 | ENST00000466788 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
5CDS-5UTR | ENST00000295874 | ENST00000468189 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
5CDS-5UTR | ENST00000295874 | ENST00000468189 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
5CDS-5UTR | ENST00000295874 | ENST00000468189 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
5CDS-5UTR | ENST00000295874 | ENST00000476844 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
5CDS-5UTR | ENST00000295874 | ENST00000476844 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
5CDS-5UTR | ENST00000295874 | ENST00000492590 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
5CDS-5UTR | ENST00000295874 | ENST00000492590 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
5CDS-5UTR | ENST00000474889 | ENST00000341848 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
5CDS-5UTR | ENST00000474889 | ENST00000466788 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
5CDS-5UTR | ENST00000474889 | ENST00000468189 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
5CDS-5UTR | ENST00000474889 | ENST00000468189 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
5CDS-5UTR | ENST00000474889 | ENST00000468189 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
5CDS-5UTR | ENST00000474889 | ENST00000476844 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
5CDS-5UTR | ENST00000474889 | ENST00000476844 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
5CDS-5UTR | ENST00000474889 | ENST00000492590 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
5CDS-5UTR | ENST00000474889 | ENST00000492590 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
5CDS-intron | ENST00000295874 | ENST00000341848 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
5CDS-intron | ENST00000295874 | ENST00000341848 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
5CDS-intron | ENST00000295874 | ENST00000466788 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
5CDS-intron | ENST00000295874 | ENST00000466788 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
5CDS-intron | ENST00000474889 | ENST00000341848 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
5CDS-intron | ENST00000474889 | ENST00000341848 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
5CDS-intron | ENST00000474889 | ENST00000466788 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60807705 | - |
5CDS-intron | ENST00000474889 | ENST00000466788 | PTPRG | chr3 | 61734656 | + | FHIT | chr3 | 60522712 | - |
In-frame | ENST00000295874 | ENST00000476844 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
In-frame | ENST00000295874 | ENST00000492590 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
In-frame | ENST00000474889 | ENST00000476844 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
In-frame | ENST00000474889 | ENST00000492590 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000495879 | ENST00000476844 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000495879 | ENST00000492590 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000495879 | ENST00000341848 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000495879 | ENST00000466788 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000495879 | ENST00000468189 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000295874 | PTPRG | chr3 | 62063932 | - | ENST00000476844 | FHIT | chr3 | 59908140 | - | 1421 | 992 | 188 | 1156 | 322 |
ENST00000295874 | PTPRG | chr3 | 62063932 | - | ENST00000492590 | FHIT | chr3 | 59908140 | - | 1432 | 992 | 188 | 1156 | 322 |
ENST00000474889 | PTPRG | chr3 | 62063932 | - | ENST00000476844 | FHIT | chr3 | 59908140 | - | 1421 | 992 | 188 | 1156 | 322 |
ENST00000474889 | PTPRG | chr3 | 62063932 | - | ENST00000492590 | FHIT | chr3 | 59908140 | - | 1432 | 992 | 188 | 1156 | 322 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000295874 | ENST00000476844 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - | 0.003435563 | 0.99656445 |
ENST00000295874 | ENST00000492590 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - | 0.003157503 | 0.9968425 |
ENST00000474889 | ENST00000476844 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - | 0.003435563 | 0.99656445 |
ENST00000474889 | ENST00000492590 | PTPRG | chr3 | 62063932 | - | FHIT | chr3 | 59908140 | - | 0.003157503 | 0.9968425 |
Top |
Fusion Genomic Features for PTPRG-FHIT |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Top |
Fusion Protein Features for PTPRG-FHIT |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:61734656/chr3:60522712) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | FHIT |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Possesses dinucleoside triphosphate hydrolase activity (PubMed:12574506, PubMed:15182206, PubMed:8794732, PubMed:9323207, PubMed:9576908, PubMed:9543008). Cleaves P(1)-P(3)-bis(5'-adenosyl) triphosphate (Ap3A) to yield AMP and ADP (PubMed:12574506, PubMed:15182206, PubMed:8794732, PubMed:9323207, PubMed:9576908, PubMed:9543008). Can also hydrolyze P(1)-P(4)-bis(5'-adenosyl) tetraphosphate (Ap4A), but has extremely low activity with ATP (PubMed:8794732). Exhibits adenylylsulfatase activity, hydrolyzing adenosine 5'-phosphosulfate to yield AMP and sulfate (PubMed:18694747). Exhibits adenosine 5'-monophosphoramidase activity, hydrolyzing purine nucleotide phosphoramidates with a single phosphate group such as adenosine 5'monophosphoramidate (AMP-NH2) to yield AMP and NH2 (PubMed:18694747). Exhibits adenylylsulfate-ammonia adenylyltransferase, catalyzing the ammonolysis of adenosine 5'-phosphosulfate resulting in the formation of adenosine 5'-phosphoramidate (PubMed:26181368). Also catalyzes the ammonolysis of adenosine 5-phosphorofluoridate and diadenosine triphosphate (PubMed:26181368). Modulates transcriptional activation by CTNNB1 and thereby contributes to regulate the expression of genes essential for cell proliferation and survival, such as CCND1 and BIRC5 (PubMed:18077326). Plays a role in the induction of apoptosis via SRC and AKT1 signaling pathways (PubMed:16407838). Inhibits MDM2-mediated proteasomal degradation of p53/TP53 and thereby plays a role in p53/TP53-mediated apoptosis (PubMed:15313915). Induction of apoptosis depends on the ability of FHIT to bind P(1)-P(3)-bis(5'-adenosyl) triphosphate or related compounds, but does not require its catalytic activity, it may in part come from the mitochondrial form, which sensitizes the low-affinity Ca(2+) transporters, enhancing mitochondrial calcium uptake (PubMed:12574506, PubMed:19622739). Functions as tumor suppressor (By similarity). {ECO:0000250|UniProtKB:O89106, ECO:0000269|PubMed:12574506, ECO:0000269|PubMed:15313915, ECO:0000269|PubMed:16407838, ECO:0000269|PubMed:18077326, ECO:0000269|PubMed:18694747, ECO:0000269|PubMed:19622739, ECO:0000269|PubMed:26181368, ECO:0000269|PubMed:8794732, ECO:0000269|PubMed:9323207, ECO:0000269|PubMed:9543008}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | FHIT | chr3:62063932 | chr3:59908140 | ENST00000341848 | 2 | 5 | 94_98 | 93 | 148.0 | Motif | Histidine triad motif | |
Tgene | FHIT | chr3:62063932 | chr3:59908140 | ENST00000468189 | 6 | 9 | 94_98 | 93 | 148.0 | Motif | Histidine triad motif | |
Tgene | FHIT | chr3:62063932 | chr3:59908140 | ENST00000476844 | 6 | 10 | 94_98 | 93 | 214.0 | Motif | Histidine triad motif | |
Tgene | FHIT | chr3:62063932 | chr3:59908140 | ENST00000492590 | 6 | 10 | 94_98 | 93 | 205.33333333333334 | Motif | Histidine triad motif |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000295874 | - | 5 | 29 | 1150_1410 | 205 | 1417.0 | Domain | Tyrosine-protein phosphatase 2 |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000295874 | - | 5 | 29 | 349_448 | 205 | 1417.0 | Domain | Fibronectin type-III |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000295874 | - | 5 | 29 | 58_321 | 205 | 1417.0 | Domain | Alpha-carbonic anhydrase |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000295874 | - | 5 | 29 | 848_1119 | 205 | 1417.0 | Domain | Tyrosine-protein phosphatase 1 |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000474889 | - | 5 | 30 | 1150_1410 | 205 | 1446.0 | Domain | Tyrosine-protein phosphatase 2 |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000474889 | - | 5 | 30 | 349_448 | 205 | 1446.0 | Domain | Fibronectin type-III |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000474889 | - | 5 | 30 | 58_321 | 205 | 1446.0 | Domain | Alpha-carbonic anhydrase |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000474889 | - | 5 | 30 | 848_1119 | 205 | 1446.0 | Domain | Tyrosine-protein phosphatase 1 |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000295874 | - | 5 | 29 | 1060_1066 | 205 | 1417.0 | Region | Substrate binding |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000474889 | - | 5 | 30 | 1060_1066 | 205 | 1446.0 | Region | Substrate binding |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000295874 | - | 5 | 29 | 20_736 | 205 | 1417.0 | Topological domain | Extracellular |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000295874 | - | 5 | 29 | 763_1445 | 205 | 1417.0 | Topological domain | Cytoplasmic |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000474889 | - | 5 | 30 | 20_736 | 205 | 1446.0 | Topological domain | Extracellular |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000474889 | - | 5 | 30 | 763_1445 | 205 | 1446.0 | Topological domain | Cytoplasmic |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000295874 | - | 5 | 29 | 737_762 | 205 | 1417.0 | Transmembrane | Helical |
Hgene | PTPRG | chr3:62063932 | chr3:59908140 | ENST00000474889 | - | 5 | 30 | 737_762 | 205 | 1446.0 | Transmembrane | Helical |
Tgene | FHIT | chr3:62063932 | chr3:59908140 | ENST00000341848 | 2 | 5 | 2_109 | 93 | 148.0 | Domain | HIT | |
Tgene | FHIT | chr3:62063932 | chr3:59908140 | ENST00000468189 | 6 | 9 | 2_109 | 93 | 148.0 | Domain | HIT | |
Tgene | FHIT | chr3:62063932 | chr3:59908140 | ENST00000476844 | 6 | 10 | 2_109 | 93 | 214.0 | Domain | HIT | |
Tgene | FHIT | chr3:62063932 | chr3:59908140 | ENST00000492590 | 6 | 10 | 2_109 | 93 | 205.33333333333334 | Domain | HIT | |
Tgene | FHIT | chr3:62063932 | chr3:59908140 | ENST00000341848 | 2 | 5 | 89_92 | 93 | 148.0 | Nucleotide binding | Substrate | |
Tgene | FHIT | chr3:62063932 | chr3:59908140 | ENST00000468189 | 6 | 9 | 89_92 | 93 | 148.0 | Nucleotide binding | Substrate | |
Tgene | FHIT | chr3:62063932 | chr3:59908140 | ENST00000476844 | 6 | 10 | 89_92 | 93 | 214.0 | Nucleotide binding | Substrate | |
Tgene | FHIT | chr3:62063932 | chr3:59908140 | ENST00000492590 | 6 | 10 | 89_92 | 93 | 205.33333333333334 | Nucleotide binding | Substrate |
Top |
Fusion Gene Sequence for PTPRG-FHIT |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>70399_70399_1_PTPRG-FHIT_PTPRG_chr3_62063932_ENST00000295874_FHIT_chr3_59908140_ENST00000476844_length(transcript)=1421nt_BP=992nt CTCAAGTTGGGGATCCTCGGCTGCTCGCCGCCGCCGCCCGCGGTCCCTGCCTGCCCCAGGCCCGGGGCATCGCCGCCGGCCGCCGACTCC GCGCCCTGCCCGATCGGCTCTCTCCTTTTTAAACGGAAAGCAGCCTTTCTCCGCCGAGAGGATCGTCCCCAGCGTGGCTCTGCGTTCCCG GTCACTTTTTGAGATTTTCCGGGGGGCGCTCGGCGGCTTCCCGGATTCCAAGGGGACTCGGGCCGCCGAGCGCGGGGGGCCCGTGGAGCG GGCGAGCCGGGGAAGCGCCCCGGCTTAGCGGAGGCTCGCACGGAGGCAAGAACTTATTCAACAAGTTTACCTCCCTGCTTTCCTCTTTTC GATGTGCGTTTTCGGACATGCGGAGGTTACTGGAACCGTGTTGGTGGATTTTGTTCCTGAAAATCACCAGTTCCGTGCTCCATTATGTCG TGTGCTTCCCCGCGTTGACAGAAGGCTACGTTGGGGCCCTGCACGAGAATAGACACGGCAGCGCAGTGCAGATCCGCAGGCGCAAGGCTT CAGGCGACCCGTACTGGGCCTACTCTGGTGCCTATGGTCCTGAGCACTGGGTCACGTCTAGTGTCAGCTGTGGGGGCCGTCACCAGTCTC CTATTGACATTTTAGACCAGTATGCGCGTGTTGGGGAAGAATACCAGGAACTGCAACTCGATGGCTTCGACAATGAGTCTTCTAACAAAA CCTGGATGAAAAACACAGGGAAAACAGTCGCCATCCTTCTGAAAGACGACTATTTTGTCAGTGGAGCTGGTCTACCTGGCAGATTCAAAG CTGAGAAGGTGGAATTTCACTGGGGCCACAGCAATGGCTCAGCGGGCTCTGAACACAGCATCAATGGCAGGAGGTTTCCTGTTGAGATGC AGATTTTCTTTTACAATCCAGATGACTTTGACAGCTTTCAAACCGCAATTTCTGAGAACAGAATAATCGGAGCCATGGCCATATTTTTTC AACACGTTCACGTCCATGTTCTTCCCAGGAAGGCTGGAGACTTTCACAGGAATGACAGCATCTATGAGGAGCTCCAGAAACATGACAAGG AGGACTTTCCTGCCTCTTGGAGATCAGAGGAGGAAATGGCAGCAGAAGCCGCAGCTCTGCGGGTCTACTTTCAGTGACACAGATCCTGAA TTCCAGCAAAAGAGCTATTGCCAACCAGTTTGAAGACCGCCCCCCGCCTCTCCCCAAGAGGAACTGAATCAGCATGAAAATGCAGTTTCT TCATCTCACCATCCTGTATTCTTCAACCAGTGATCCCCCACCTCGGTCACTCCAACTCCCTTAAAATACCTAGACCTAAACGGCTCAGAC >70399_70399_1_PTPRG-FHIT_PTPRG_chr3_62063932_ENST00000295874_FHIT_chr3_59908140_ENST00000476844_length(amino acids)=322AA_BP=266 MRFSGGRSAASRIPRGLGPPSAGGPWSGRAGEAPRLSGGSHGGKNLFNKFTSLLSSFRCAFSDMRRLLEPCWWILFLKITSSVLHYVVCF PALTEGYVGALHENRHGSAVQIRRRKASGDPYWAYSGAYGPEHWVTSSVSCGGRHQSPIDILDQYARVGEEYQELQLDGFDNESSNKTWM KNTGKTVAILLKDDYFVSGAGLPGRFKAEKVEFHWGHSNGSAGSEHSINGRRFPVEMQIFFYNPDDFDSFQTAISENRIIGAMAIFFQHV -------------------------------------------------------------- >70399_70399_2_PTPRG-FHIT_PTPRG_chr3_62063932_ENST00000295874_FHIT_chr3_59908140_ENST00000492590_length(transcript)=1432nt_BP=992nt CTCAAGTTGGGGATCCTCGGCTGCTCGCCGCCGCCGCCCGCGGTCCCTGCCTGCCCCAGGCCCGGGGCATCGCCGCCGGCCGCCGACTCC GCGCCCTGCCCGATCGGCTCTCTCCTTTTTAAACGGAAAGCAGCCTTTCTCCGCCGAGAGGATCGTCCCCAGCGTGGCTCTGCGTTCCCG GTCACTTTTTGAGATTTTCCGGGGGGCGCTCGGCGGCTTCCCGGATTCCAAGGGGACTCGGGCCGCCGAGCGCGGGGGGCCCGTGGAGCG GGCGAGCCGGGGAAGCGCCCCGGCTTAGCGGAGGCTCGCACGGAGGCAAGAACTTATTCAACAAGTTTACCTCCCTGCTTTCCTCTTTTC GATGTGCGTTTTCGGACATGCGGAGGTTACTGGAACCGTGTTGGTGGATTTTGTTCCTGAAAATCACCAGTTCCGTGCTCCATTATGTCG TGTGCTTCCCCGCGTTGACAGAAGGCTACGTTGGGGCCCTGCACGAGAATAGACACGGCAGCGCAGTGCAGATCCGCAGGCGCAAGGCTT CAGGCGACCCGTACTGGGCCTACTCTGGTGCCTATGGTCCTGAGCACTGGGTCACGTCTAGTGTCAGCTGTGGGGGCCGTCACCAGTCTC CTATTGACATTTTAGACCAGTATGCGCGTGTTGGGGAAGAATACCAGGAACTGCAACTCGATGGCTTCGACAATGAGTCTTCTAACAAAA CCTGGATGAAAAACACAGGGAAAACAGTCGCCATCCTTCTGAAAGACGACTATTTTGTCAGTGGAGCTGGTCTACCTGGCAGATTCAAAG CTGAGAAGGTGGAATTTCACTGGGGCCACAGCAATGGCTCAGCGGGCTCTGAACACAGCATCAATGGCAGGAGGTTTCCTGTTGAGATGC AGATTTTCTTTTACAATCCAGATGACTTTGACAGCTTTCAAACCGCAATTTCTGAGAACAGAATAATCGGAGCCATGGCCATATTTTTTC AACACGTTCACGTCCATGTTCTTCCCAGGAAGGCTGGAGACTTTCACAGGAATGACAGCATCTATGAGGAGCTCCAGAAACATGACAAGG AGGACTTTCCTGCCTCTTGGAGATCAGAGGAGGAAATGGCAGCAGAAGCCGCAGCTCTGCGGGTCTACTTTCAGTGACACAGATGTTTTT CAGATCCTGAATTCCAGCAAAAGAGCTATTGCCAACCAGTTTGAAGACCGCCCCCCGCCTCTCCCCAAGAGGAACTGAATCAGCATGAAA ATGCAGTTTCTTCATCTCACCATCCTGTATTCTTCAACCAGTGATCCCCCACCTCGGTCACTCCAACTCCCTTAAAATACCTAGACCTAA >70399_70399_2_PTPRG-FHIT_PTPRG_chr3_62063932_ENST00000295874_FHIT_chr3_59908140_ENST00000492590_length(amino acids)=322AA_BP=266 MRFSGGRSAASRIPRGLGPPSAGGPWSGRAGEAPRLSGGSHGGKNLFNKFTSLLSSFRCAFSDMRRLLEPCWWILFLKITSSVLHYVVCF PALTEGYVGALHENRHGSAVQIRRRKASGDPYWAYSGAYGPEHWVTSSVSCGGRHQSPIDILDQYARVGEEYQELQLDGFDNESSNKTWM KNTGKTVAILLKDDYFVSGAGLPGRFKAEKVEFHWGHSNGSAGSEHSINGRRFPVEMQIFFYNPDDFDSFQTAISENRIIGAMAIFFQHV -------------------------------------------------------------- >70399_70399_3_PTPRG-FHIT_PTPRG_chr3_62063932_ENST00000474889_FHIT_chr3_59908140_ENST00000476844_length(transcript)=1421nt_BP=992nt CTCAAGTTGGGGATCCTCGGCTGCTCGCCGCCGCCGCCCGCGGTCCCTGCCTGCCCCAGGCCCGGGGCATCGCCGCCGGCCGCCGACTCC GCGCCCTGCCCGATCGGCTCTCTCCTTTTTAAACGGAAAGCAGCCTTTCTCCGCCGAGAGGATCGTCCCCAGCGTGGCTCTGCGTTCCCG GTCACTTTTTGAGATTTTCCGGGGGGCGCTCGGCGGCTTCCCGGATTCCAAGGGGACTCGGGCCGCCGAGCGCGGGGGGCCCGTGGAGCG GGCGAGCCGGGGAAGCGCCCCGGCTTAGCGGAGGCTCGCACGGAGGCAAGAACTTATTCAACAAGTTTACCTCCCTGCTTTCCTCTTTTC GATGTGCGTTTTCGGACATGCGGAGGTTACTGGAACCGTGTTGGTGGATTTTGTTCCTGAAAATCACCAGTTCCGTGCTCCATTATGTCG TGTGCTTCCCCGCGTTGACAGAAGGCTACGTTGGGGCCCTGCACGAGAATAGACACGGCAGCGCAGTGCAGATCCGCAGGCGCAAGGCTT CAGGCGACCCGTACTGGGCCTACTCTGGTGCCTATGGTCCTGAGCACTGGGTCACGTCTAGTGTCAGCTGTGGGGGCCGTCACCAGTCTC CTATTGACATTTTAGACCAGTATGCGCGTGTTGGGGAAGAATACCAGGAACTGCAACTCGATGGCTTCGACAATGAGTCTTCTAACAAAA CCTGGATGAAAAACACAGGGAAAACAGTCGCCATCCTTCTGAAAGACGACTATTTTGTCAGTGGAGCTGGTCTACCTGGCAGATTCAAAG CTGAGAAGGTGGAATTTCACTGGGGCCACAGCAATGGCTCAGCGGGCTCTGAACACAGCATCAATGGCAGGAGGTTTCCTGTTGAGATGC AGATTTTCTTTTACAATCCAGATGACTTTGACAGCTTTCAAACCGCAATTTCTGAGAACAGAATAATCGGAGCCATGGCCATATTTTTTC AACACGTTCACGTCCATGTTCTTCCCAGGAAGGCTGGAGACTTTCACAGGAATGACAGCATCTATGAGGAGCTCCAGAAACATGACAAGG AGGACTTTCCTGCCTCTTGGAGATCAGAGGAGGAAATGGCAGCAGAAGCCGCAGCTCTGCGGGTCTACTTTCAGTGACACAGATCCTGAA TTCCAGCAAAAGAGCTATTGCCAACCAGTTTGAAGACCGCCCCCCGCCTCTCCCCAAGAGGAACTGAATCAGCATGAAAATGCAGTTTCT TCATCTCACCATCCTGTATTCTTCAACCAGTGATCCCCCACCTCGGTCACTCCAACTCCCTTAAAATACCTAGACCTAAACGGCTCAGAC >70399_70399_3_PTPRG-FHIT_PTPRG_chr3_62063932_ENST00000474889_FHIT_chr3_59908140_ENST00000476844_length(amino acids)=322AA_BP=266 MRFSGGRSAASRIPRGLGPPSAGGPWSGRAGEAPRLSGGSHGGKNLFNKFTSLLSSFRCAFSDMRRLLEPCWWILFLKITSSVLHYVVCF PALTEGYVGALHENRHGSAVQIRRRKASGDPYWAYSGAYGPEHWVTSSVSCGGRHQSPIDILDQYARVGEEYQELQLDGFDNESSNKTWM KNTGKTVAILLKDDYFVSGAGLPGRFKAEKVEFHWGHSNGSAGSEHSINGRRFPVEMQIFFYNPDDFDSFQTAISENRIIGAMAIFFQHV -------------------------------------------------------------- >70399_70399_4_PTPRG-FHIT_PTPRG_chr3_62063932_ENST00000474889_FHIT_chr3_59908140_ENST00000492590_length(transcript)=1432nt_BP=992nt CTCAAGTTGGGGATCCTCGGCTGCTCGCCGCCGCCGCCCGCGGTCCCTGCCTGCCCCAGGCCCGGGGCATCGCCGCCGGCCGCCGACTCC GCGCCCTGCCCGATCGGCTCTCTCCTTTTTAAACGGAAAGCAGCCTTTCTCCGCCGAGAGGATCGTCCCCAGCGTGGCTCTGCGTTCCCG GTCACTTTTTGAGATTTTCCGGGGGGCGCTCGGCGGCTTCCCGGATTCCAAGGGGACTCGGGCCGCCGAGCGCGGGGGGCCCGTGGAGCG GGCGAGCCGGGGAAGCGCCCCGGCTTAGCGGAGGCTCGCACGGAGGCAAGAACTTATTCAACAAGTTTACCTCCCTGCTTTCCTCTTTTC GATGTGCGTTTTCGGACATGCGGAGGTTACTGGAACCGTGTTGGTGGATTTTGTTCCTGAAAATCACCAGTTCCGTGCTCCATTATGTCG TGTGCTTCCCCGCGTTGACAGAAGGCTACGTTGGGGCCCTGCACGAGAATAGACACGGCAGCGCAGTGCAGATCCGCAGGCGCAAGGCTT CAGGCGACCCGTACTGGGCCTACTCTGGTGCCTATGGTCCTGAGCACTGGGTCACGTCTAGTGTCAGCTGTGGGGGCCGTCACCAGTCTC CTATTGACATTTTAGACCAGTATGCGCGTGTTGGGGAAGAATACCAGGAACTGCAACTCGATGGCTTCGACAATGAGTCTTCTAACAAAA CCTGGATGAAAAACACAGGGAAAACAGTCGCCATCCTTCTGAAAGACGACTATTTTGTCAGTGGAGCTGGTCTACCTGGCAGATTCAAAG CTGAGAAGGTGGAATTTCACTGGGGCCACAGCAATGGCTCAGCGGGCTCTGAACACAGCATCAATGGCAGGAGGTTTCCTGTTGAGATGC AGATTTTCTTTTACAATCCAGATGACTTTGACAGCTTTCAAACCGCAATTTCTGAGAACAGAATAATCGGAGCCATGGCCATATTTTTTC AACACGTTCACGTCCATGTTCTTCCCAGGAAGGCTGGAGACTTTCACAGGAATGACAGCATCTATGAGGAGCTCCAGAAACATGACAAGG AGGACTTTCCTGCCTCTTGGAGATCAGAGGAGGAAATGGCAGCAGAAGCCGCAGCTCTGCGGGTCTACTTTCAGTGACACAGATGTTTTT CAGATCCTGAATTCCAGCAAAAGAGCTATTGCCAACCAGTTTGAAGACCGCCCCCCGCCTCTCCCCAAGAGGAACTGAATCAGCATGAAA ATGCAGTTTCTTCATCTCACCATCCTGTATTCTTCAACCAGTGATCCCCCACCTCGGTCACTCCAACTCCCTTAAAATACCTAGACCTAA >70399_70399_4_PTPRG-FHIT_PTPRG_chr3_62063932_ENST00000474889_FHIT_chr3_59908140_ENST00000492590_length(amino acids)=322AA_BP=266 MRFSGGRSAASRIPRGLGPPSAGGPWSGRAGEAPRLSGGSHGGKNLFNKFTSLLSSFRCAFSDMRRLLEPCWWILFLKITSSVLHYVVCF PALTEGYVGALHENRHGSAVQIRRRKASGDPYWAYSGAYGPEHWVTSSVSCGGRHQSPIDILDQYARVGEEYQELQLDGFDNESSNKTWM KNTGKTVAILLKDDYFVSGAGLPGRFKAEKVEFHWGHSNGSAGSEHSINGRRFPVEMQIFFYNPDDFDSFQTAISENRIIGAMAIFFQHV -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PTPRG-FHIT |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PTPRG-FHIT |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for PTPRG-FHIT |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | PTPRG | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human |
Hgene | PTPRG | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Hgene | PTPRG | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human |
Tgene | C0024121 | Lung Neoplasms | 2 | CTD_human | |
Tgene | C0025500 | Mesothelioma | 2 | CTD_human | |
Tgene | C0242379 | Malignant neoplasm of lung | 2 | CTD_human | |
Tgene | C0007097 | Carcinoma | 1 | CTD_human | |
Tgene | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human | |
Tgene | C0013146 | Drug abuse | 1 | CTD_human | |
Tgene | C0013170 | Drug habituation | 1 | CTD_human | |
Tgene | C0013222 | Drug Use Disorders | 1 | CTD_human | |
Tgene | C0023903 | Liver neoplasms | 1 | CTD_human | |
Tgene | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human | |
Tgene | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human | |
Tgene | C0033578 | Prostatic Neoplasms | 1 | CTD_human | |
Tgene | C0038356 | Stomach Neoplasms | 1 | CTD_human | |
Tgene | C0038580 | Substance Dependence | 1 | CTD_human | |
Tgene | C0038586 | Substance Use Disorders | 1 | CTD_human | |
Tgene | C0042076 | Urologic Neoplasms | 1 | CTD_human | |
Tgene | C0205696 | Anaplastic carcinoma | 1 | CTD_human | |
Tgene | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human | |
Tgene | C0205698 | Undifferentiated carcinoma | 1 | CTD_human | |
Tgene | C0205699 | Carcinomatosis | 1 | CTD_human | |
Tgene | C0236733 | Amphetamine-Related Disorders | 1 | CTD_human | |
Tgene | C0236804 | Amphetamine Addiction | 1 | CTD_human | |
Tgene | C0236807 | Amphetamine Abuse | 1 | CTD_human | |
Tgene | C0236969 | Substance-Related Disorders | 1 | CTD_human | |
Tgene | C0345904 | Malignant neoplasm of liver | 1 | CTD_human | |
Tgene | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human | |
Tgene | C0740858 | Substance abuse problem | 1 | CTD_human | |
Tgene | C0751571 | Cancer of Urinary Tract | 1 | CTD_human | |
Tgene | C1510472 | Drug Dependence | 1 | CTD_human | |
Tgene | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human | |
Tgene | C4316881 | Prescription Drug Abuse | 1 | CTD_human |